You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

OXYPHENBUTAZONE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for oxyphenbutazone and what is the scope of freedom to operate?

Oxyphenbutazone is the generic ingredient in two branded drugs marketed by Watson Labs and Novartis, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for oxyphenbutazone.

Summary for OXYPHENBUTAZONE
Recent Clinical Trials for OXYPHENBUTAZONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all OXYPHENBUTAZONE clinical trials

Medical Subject Heading (MeSH) Categories for OXYPHENBUTAZONE

US Patents and Regulatory Information for OXYPHENBUTAZONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs OXYPHENBUTAZONE oxyphenbutazone TABLET;ORAL 088399-001 Sep 17, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novartis TANDEARIL oxyphenbutazone TABLET;ORAL 012542-004 Sep 3, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.